


Company Information
Ask for more detail from the seller
Contact SupplierCOATS® (an acronym for Colloidal Oatmeal System) is a patented and unique nitrile glove technology. COATS® utilises the powerful benefits of all-natural oats, an FDA-recognised skin protectant, as a coating that forms a natural, moisturising barrier between the glove and skin. This acts as a preventative measure against skin irritation, and eliminates uncomfortable and irritating conditions experienced when wearing normal gloves. Users who suffer from dry and itchy skin due to frequent hand washing and glove usage can now rely on COATS® to soothe and nurture the skin, and protect their hands while they work.
Regulations Compliance
International Standards
Manufacturing Accreditations
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a COATS® nitrile glove at 21.9 minutes and 36.0 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.
| REORDER CODE | SIZE |
|---|---|
| CTS38XS | X-Small |
| CTS38SS | Small |
| CTS38MM | Medium |
| CTS38LL | Large |
| CTS38XL | X-Large |
| PHYSICAL PROPERTIES | BEFORE AGEING | AFTER AGEING |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥400 |
| INSPECTION LEVELS AND AQL | INSPECTION LEVEL | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4 |
| Tensile Strength | S2 | 4 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Colloidal Oatmeal Content | N=5 | ≥5mg/glove |
| Chemotherapy Drugs and Concentration (tested for Resistance to Permeation By Chemotherapy Drugs as Per ASTM D6978-05, Test Report Pn 134889A) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 21.9 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 36 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |

